Page last updated: 2024-10-30

lomerizine and Atrophy

lomerizine has been researched along with Atrophy in 2 studies

lomerizine: used to treat migraines

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research Excerpts

ExcerptRelevanceReference
" The patient was administered lomerizine (10 mg/day), but the patient's cognitive impairment and cerebral atrophy continued to worsen."7.88[CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report]. ( Kuriyama, M; Mizuno, T; Mizuta, I; Shiga, Y; Shimoe, Y; Tachiyama, K, 2018)
" The patient was administered lomerizine (10 mg/day), but the patient's cognitive impairment and cerebral atrophy continued to worsen."3.88[CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report]. ( Kuriyama, M; Mizuno, T; Mizuta, I; Shiga, Y; Shimoe, Y; Tachiyama, K, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tachiyama, K1
Shiga, Y1
Shimoe, Y1
Mizuta, I1
Mizuno, T1
Kuriyama, M1
Hara, H1
Harada, K1
Sukamoto, T1

Other Studies

2 other studies available for lomerizine and Atrophy

ArticleYear
[CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report].
    Rinsho shinkeigaku = Clinical neurology, 2018, Apr-25, Volume: 58, Issue:4

    Topics: Atrophy; Brain; CADASIL; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Cysteine; Di

2018
Chronological atrophy after transient middle cerebral artery occlusion in rats.
    Brain research, 1993, Aug-06, Volume: 618, Issue:2

    Topics: Animals; Atrophy; Brain; Calcium Channel Blockers; Cerebral Arteries; Excitatory Amino Acid Antagoni

1993